Diabetes, Alzheimer's disease and apolipoprotein genotype

Experimental Gerontology

Volumn 38, Issue 9, 2003, Pages 941-946

  Messier, Claude ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Alzheimer's disease; Brain metabolism; Diabetes; Glucose; Insulin; Memory

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN E4;

ALLELE; ALZHEIMER DISEASE; BRAIN METABOLISM; COGNITIVE DEFECT; DEMENTIA; DISEASE ASSOCIATION; GENOTYPE; HUMAN; INSULIN SENSITIVITY; MORBIDITY; MULTIINFARCT DEMENTIA; NEUROFIBRILLARY TANGLE; NEUROPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RETINOPATHY; REVIEW; RISK FACTOR; VASCULAR DISEASE;

EID: 0042385094     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0531-5565(03)00153-0     Document Type: Review

References (51)

1. Awad N., Gagnon M., Desrochers A., Tsiakas M., Messier C. Impact of peripheral glucoregulation on memory. Behav. Neurosci. 116:2002;691-702.
2. Balasubramanian A.S. Amyloid beta peptide processing, insulin degrading enzyme, and butyrylcholinesterase. Neurochem. Res. 26:2001;453-456.
3. Boyt A.A., Taddei T.K., Hallmayer J., Helmerhorst E., Gandy S.E., Craft S., Martins R.N. The effect of insulin and glucose on the plasma concentration of Alzheimer's amyloid precursor protein. Neurosci. 95:2000;727-734.
4. Brayne C., Gill C., Huppert F.A., Barkley C., Gehlhaar E., Girling D.M., O'Connor D.W., Paykel E.S. Vascular risks and incident dementia: results from a cohort study of the very old. Dement. Geriatr. Cogn. Disord. 9:1998;175-180.
5. Bucht G., Adolfsson R., Lithner F., Winblad B. Changes in blood glucose and insulin secretion in patients with senile dementia of alzheimer type. Acta. Med. Scand. 213:1983;387-392.
6. Convit A., Wolf O.T., Tarshish C., De Leon M.J. Reduced glucose tolerance is associated with poor memory performance and hippocampal atrophy among normal elderly. Proc. Natl. Acad. Sci. USA. 100:2003;2019-2022.
7. Cook D.G., Leverenz J.B., McMillan P.J., Kulstad J.J., Ericksen S., Roth R.A., Schellenberg G.D., Jin L.W., Kovacina K.S., Craft S. Reduced hipocampal insulin-degrading enzyme in late-onset Alzheimer's disease is associated with the apolipoprotein E-epislon4 allele. Am. J. Pathol. 162:2003.
8. Craft S., Peskind E., Schwartz M.W., Schellenberg G.D., Raskind M., Porte D. Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: relationship to severity of dementia and apolipoprotein E genotype. Neurology. 50(1):1998;164-168.
9. Craft S., Asthana S., Newcomer J.W., Wilkinson C.W., Matos I.T., Baker L.D., Cherrier M., Lofgreen C., Latendresse S., Petrova A., Plymate S., Raskind M., Grimwood K., Veith R.C. Enhancement of memory in Alzheimer disease with insulin and somatostatin, but not glucose. Arch. Gen. Psychiat. 56:1999;1135-1140.
10. Craft S., Asthana S., Schellenberg G., Baker L., Cherrier M., Boyt A.A., Martins R.N., Raskind M., Peskind E., Plymate S. Insulin effects on glucose metabolism, memory, and plasma amyloid precursor protein in Alzheimer's disease differ according to apolipoprotein-E genotype. Ann. N. Y. Acad. Sci. 903:2000;222-228.
11. Craft S., Asthana S., Schellenberg G., Cherrier M., Baker L.D., Newcomer J., Plymate S., Latendresse S., Petrova A., Raskind M., Peskind E., Lofgreen C., Grimwood K. Insulin metabolism in alzheimer's disease differs according to apolipoprotein e genotype and gender. Neuroendocrinology. 70:1999;146-152.
12. Craft S., Dagogo-Jack S.E., Wiethop B.V., Murphy C., Nevins R.T., Fleischman S., Rice V., Newcomer J.W., Cryer P.E. Effects of hyperglycemia on memory and hormone levels in dementia of the Alzheimer type: a longitudinal study. Behav. Neurosci. 107:1993;926-940.
13. Craft S., Newcomer J., Kanne S., Dagogo-Jack S., Cryer P., Sheline Y., Luby J., Dagogo-Jack A., Alderson A. Memory Improvement following induced hyperinsulinemia in Alzheimer's Disease. Neurobiol. Aging. 17:1996;123-130.
14. Craft S., Zallen G., Baker L.D. Glucose and memory in mild senile dementia of the Alzheimer type. J. Clin. Exp. Neuropsychol. 14:1992;253-267.
15. Curb J.D., Rodriguez B.L., Abbott R.D., Petrovitch H., Ross G.W., Masaki K.H., Foley D., Blanchette P.L., Harris T., Chen R., White L.R. Longitudinal association of vascular and Alzheimer's dementias, diabetes, and glucose tolerance. Neurology. 52:1999;971-975.
16. Edbauer D., Willem M., Lammich S., Steiner H., Haass C. Insulin-degrading enzyme rapidly removes the beta-amyloid precursor protein intracellular domain (AICD). J. Biol. Chem. 277:2002;13389-13393.
17. Fisman M., Gordon B., Feleki V., Helmes E., McDonald T., Dupre J. Metabolic changes in Alzheimer's disease. J. Am. Geriatr. Soc. 36:1988;298-300.
18. Fontbonne A., Berr C., Ducimetiere P., Alperovitch A. Changes in cognitive abilities over a 4-year period are unfavorably affected in elderly diabetic subjects: results of the epidemiology of vascular aging study. Diabetes Care. 24:2001;366-370.
19. Fujisawa Y., Sasaki K., Akiyama K. Increased insulin levels after OGTT load in peripheral blood and cerebrospinal fluid of patients with dementia of Alzheimer type. Biol. Psychiat. 30:1991;1219-1228.
20. Gonzalez C., Martin T., Cacho J., Brenas M.T., Arroyo T., Garcia-Berrocal B., Navajo J.A., Gonzalez-Buitrago J.M. Serum zinc, copper, insulin and lipids in Alzheimer's disease epsilon 4 apolipoprotein E allele carriers. Eur. J. Clin. Invest. 29:1999;637-642.
21. Gradman T.J., Laws A., Thompson L.W., Reaven G.M. Verbal learning and/or memory improves with glycemic control in older subjects with non-insulin-dependent diabetes mellitus. J. Am. Geriatr. Soc. 41:1993;1305-1312.
22. Grodstein F., Chen J., Wilson R.S., Manson J.E. Type 2 diabetes and cognitive function in community-dwelling elderly women. Diabetes Care. 24:2001;1060-1065.
23. Heitner J., Dickson D. Diabetics do not have increased Alzheimer-type pathology compared with age-matched control subjects. A retrospective postmortem immunocytochemical and histofluorescent study. Neurology. 49:1997;1306-1311.
24. Helkala E.L., Lakka T., Vanhanen M., Tuomainen T.P., Ehnholm C., Kaplan G.A., Salonen J.T. Associations between apolipoprotein E phenotype, glucose metabolism and cognitive function in men. An explorative study in a population sample. Diabet. Med. 18:2001;991-997.
25. Kaplan R.J., Greenwood C.E., Winocur G., Wolever T.M.S. Cognitive performance is associated with glucose regulation in healthy elderly persons and can be enhanced with glucose and dietary carbohydrates. Am. J. Clin. Nutr. 72:2000;825-836.
26. Kilander L., Boberg M., Lithell H. Peripheral glucose metabolism and insulin sensitivity in Alzheimer's disease. Acta. Neurol. Scand. 87:1993;294-298.
27. Kuusisto J., Koivisto K., Mykkanen L., Helkala E.L., Vanhanen M., Hanninen T., Kervinen K., Kesaniemi Y.A., Riekkinen P.J., Laakso M. Association between features of the insulin resistance syndrome and Alzheimer's disease independently of apolipoprotein E4 phenotype: cross sectional population based study. Bmj. 315:1997;1045-1049.
28. Landin K., Blennow K., Wallin A., Gottfries C.G. Low blood pressure and blood glucose levels in Alzheimer's disease. Evidence for a hypometabolic disorder? J. Intern. Med. 233:1993;357-363.
29. Leibson C.L., Rocca W.A., Hanson V.A., Cha R., Kokmen E., O'Brien P.C., Palumbo P.J. Risk of dementia among persons with diabetes mellitus: a population-based cohort study. Am. J. Epidemiol. 145:1997;301-308.
30. Leibson C.L., Rocca W.A., Hanson V.A., Cha R., Kokmen E., Obrien P.C., Palumbo P.J. Risk of dementia among persons with diabetes mellitus: A population-based cohort study. Am. J. Epidemiol. 145:1997;301-308.
31. Luchsinger J.A., Tang M.X., Stern Y., Shea S., Mayeux R. Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort. Am. J. Epidemiol. 154:2001;635-641.
32. MacKnight C., Rockwood K., Awalt E., McDowell I. Diabetes mellitus and the risk of dementia, Alzheimer's disease and vascular cognitive impairment in the Canadian Study of Health and Aging. Dement. Geriatr. Cogn. Disord. 14:2002;77-83.
33. McDowell I. Alzheimer's disease: insights from epidemiology. Aging (Milano). 13:2001;143-162.
34. Meneilly G.S., Cheung E., Tessier D., Yakura C., Tuokko H. The effect of improved glycemic control on cognitive functions in the elderly patient with diabetes. J. Gerontol. 48:1993;M117-M121.
35. Meneilly G.S., Hill A. Alterations in glucose metabolism in patients with Alzheimer's disease. J. Am. Geriatr. Soc. 41:1993;710-714.
36. Messier C., Gagnon M. Glucose regulation and cognitive functions: relation to Alzheimer's Disease and diabetes. Behav. Brain Res. 75:1996;1-11.
37. Messier C., Gagnon M. Glucose regulation and brain aging. J. Nutr. Health Aging. 4:2000;208-213.
38. Messier C., Tsiakas M., Gargnon M., Desrochers A., Awad N. Effect of age and glucoregulation on cognitive performance. Neurobiol. Aging. 24(7):2003;985-1003.
39. Mooradian A.D. Pathophysiology of central nervous system complications in diabetes mellitus. Clin. Neurosci. 4:1997;322-326.
40. Mortel K.F., Wood S., Pavol M.A., Meyer J.S., Rexer J.L. Analysis of familial and individual risk factors among patients with ischemic vascular dementia and Alzheimer's disease. Angiology. 44:1993;599-605.
41. Nielson K.A., Nolan J.H., Berchtold N.C., Sandman C.A., Mulnard R.A., Cotman C.W. Apolipoprotein-E genotyping of diabetic dementia patients: is diabetes rare in Alzheimer's disease? J. Am. Geriatrics Soc. 44:1996;897-904. see comments.
42. Ott A., Stolk R.P., Hofman A., van Harskamp F., Grobbee D.E., Breteler M.M. Association of diabetes mellitus and dementia: the Rotterdam Study. Diabetologia. 39:1996;1392-1397.
43. Ott A., Stolk R.P., van Harskamp F., Pols H.A., Hofman A., Breteler M.M. Diabetes mellitus and the risk of dementia: the Rotterdam study. Neurology. 53:1942;1937-1942.
44. Peila R., Rodriguez B.L., Launer L.J. Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies - The Honolulu-Asia Aging Study. Diabetes. 51:2002;1256-1262.
45. Radziuk J. Insulin sensitivity and its measurement: structural commonalities among the methods. J. Clin. Endocrinol. Metab. 85:2000;4426-4433.
46. Ryan C.M., Geckle M. Why is learning and memory dysfunction in Type 2 diabetes limited to older adults? Diabetes Metab. Res. Rev. 16:2000;308-315.
47. Small G.W., Ercoli L.M., Silverman D.H., Huang S.C., Komo S., Bookheimer S.Y., Lavretsky H., Miller K., Siddarth P., Rasgon N.L., Mazziotta J.C., Saxena S., Wu H.M., Mega M.S., Cummings J.L., Saunders A.M., Pericak-Vance M.A., Roses A.D., Barrio J.R., Phelps M.E. Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. Proc. Nat. Acad. Sci. USA. 97:2000;6037-6042.
48. Stewart R., Liolitsa D. Type 2 diabetes mellitus, cognitive impairment and dementia. Diabet. Med. 16:1999;93-112.
49. Strachan M.W., Deary I.J., Ewing F.M., Frier B.M. Is type II diabetes associated with an increased risk of cognitive dysfunction?. A critical review of published studies. Diabetes Care. 20:1997;438-445.
50. Winograd C.H., Jacobson D.H., Minkoff J.R., Peabody C.A., Taylor B.S., Widrow L., Yesavage J.A. Blood glucose and insulin response in patients with senile dementia of the Alzheimer's type. Biol. Psychiat. 30:1991;507-511.
51. Xie L., Helmerhorst E., Taddei K., Plewright B., Van Bronswijk W., Martins R. Alzheimer's beta-amyloid peptides compete for insulin binding to the insulin receptor. J. Neurosci. 22:2002;RC221.